While the spread of coronavirus in the United States is on an increase, the number of cases in China, where the virus originated has reportedly slowed down.
The deadly virus originated in Wuhan, China, where not coincidentally the nation’s only Level-4 biomedical super-lab is located, and where they work on the world’s most deadly pathogens including coronavirus.
On January 30, the Washington Times wrote – Senator Tom Cotton warned about the source of the coronavirus outbreak in China, saying, “[China] also claimed for almost two months, until earlier this week, that it had originated in a seafood market in Wuhan. That locals had contracted it from animals in say bat soup or snake tartar,” said Cotton. “That is not the case.”
The Arkansas Republican cited a study published by the Lancet that showed of the original 40 cases in Wuhan, the epicenter of the outbreak, 14 people who contracted the virus never set foot in the Wuhan wildlife market where Chinese authorities have claimed the virus originated.
“As one epidemiologist said, ‘That virus went into the seafood market before it came out of the seafood market.’ We still don’t know where it originated,” Cotton said. “I would note that Wuhan also has China’s only biosafety level four super laboratory that works with the world’s most deadly pathogens to include, yes, coronavirus.”
The Washington Times reported last week that Wuhan Institute of Virology is the only laboratory in China capable of working with such deadly pathogens.
Watch Republican Senator Tom Cotton talk about his concerns about where the coronavirus originated.
China claimed—for almost two months—that coronavirus had originated in a Wuhan seafood market. That is not the case. @TheLancet published a study demonstrating that of the original 40 cases, 14 of them had no contact with the seafood market, including Patient Zero. pic.twitter.com/PdgqgHjkGy
— Tom Cotton (@SenTomCotton) January 30, 2020
Communist China is now reportedly threatening the U.S. with access to life-saving coronavirus drugs.
According to Fox News- The global spread of the coronavirus has started to affect the supply of antibiotics and vitamins out of India and China.
While a few factories in India have started producing products again, shortages of some drugs could develop, experts warn.
On Tuesday, authorities in India ordered the country’s pharmaceutical industry to stop exporting 26 drugs and ingredients used in antibiotics without explicit permission from the government. The moves made in India will undoubtedly have an effect on the rest of the world, which relies on the Asian nation’s drug makers for much of its supply of generic drugs.
According to the India Brand Equity Foundation, India exported about $19 billion in drugs in 2019, accounting for about one-fifth of the world’s exports of generics by volume.
In an article in Xinhua, the state-run media agency that’s largely considered the mouthpiece of the party, Beijing bragged about its handling of COVID-19, a virus that originated in the city of Wuhan and has spread quickly around the world, killing nearly 5,000 people and infecting thousands more. The article also claimed that China could impose pharmaceutical export controls which would plunge America into “the mighty sea of coronavirus.”
Senator Marco Rubio (R-FL) spoke with Fox News host Brian Kilmeade about the anticipated shortage of drugs needed to combat the coronavirus. Rubio warned about the “tremendous amount of leverage” China has over Americans when it comes to the control communist China has over our drug supply.
The disturbing threats made during a global pandemic as well as the scary consequences if that threat becomes real highlight just how tight China’s grip is on the global supply chain. Already, the Food and Drug Administration has announced the first drug shortage related to the coronavirus. Though it did not disclose which drug was in short supply, the FDA did say it could not access enough raw components needed because they are made in China.